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A METHOD FOR PROTECTION OF PATIENTS WITH SOLAR URTICARIA'
Louis RUBIN, M.D., PETER L. BEAL, M.D., AND STEPHEN ROTHMAN, M.D.
For several years two patients suffering from solar urticaria have been under observation
at the University of Chicago Clinics. Both belong to the type X < 3700A of Blum, Bacr and
Suixherger (1). During administration of "antihistaininic'' substances ihcre was an avcr
age six fold increase in tolerance to light. Detailed data on these experiments will be pub-
lished later (2). Under antihistaminic medication, both patients noticed that the face and
neck became even more tolerant to sunshine than the usually covered parts of the body.
Apparently, nnder the protection of antihistaminic substances the patients exposed them-
selves more intensely to sunshine than they were able to do before medication. Subse-
quently, local changes occurred wbich increased the tolerance of the exposed parts indepen-
dent of tho general effect of antihistaminic substances. The local changes might have been
melanin pigmentation and/or thickening of the horny layer (3). Either might have inter-
fered with the penetration of the antigenic wavelengths.
On one of the patients the following study was done. During Pyrihenzamino medica-
tion (50 milligrams, 3 times daily) daily irradiations were given with an artificial sun lamp
to the whole body surface except the lower abdomen which was kept covered throughout the
whole experiment. The initial exposure time and the slow increase of the dosage was graded
so as to avoid immediate allergic reactions as well as sunburn. After 37 exposures, wbon
marked tanning was present, the dose of Pyribenzamine was reduced to 50 milligrams twice
daily, and after a total of 44 exposures to 50 milligrams once daily, this dose being given one
hour before irradiation . After 54 exposures Pyribenzaminc medication was discontinued.
Daily irradiations, however, have been continued.
Fourteen days after discontinuation of Pyrihenzamine administration, sensitivity tests
were done on both the upper (exposed) and lower (unexposed) parts of the abdomen. The
threshold value for whealing (triple response) on the unexposed part was 20 seconds at 29
inches. On the exposed (pigmented) part no whealing, no local erythema, no flare and no
itching could be elicited up to 260 seconds at 7f inches. Exposure for 260 seconds at 7
inches is equal in effect to an exposure for 4160 seconds at 29 inches. Thus, the irradiated
parts acquired a tolerance more than 200 times greater than that of the covered parts.
cONcLUSIONs
By virtue of tbe mildly protective action of "antihistaminic" substances it has become
possible to subject patients with solar urticaria to gradually increasing ultraviolet light
exposures. By this treatment the skin acquires such tolerance that the administration of
antihistaminic substances can be discontinued. Whereas these drugs in average doses in-
crease the tolerance only six times, the increase in tolerance by continued ultraviolet irra-
diations is greater than 200 fold. Obviously, as long as daily irradiations are given, this
high degree of protection will persist. The effect of irradiations is local and due to pigmen-
tation and/or thickening of the horny layer whereby the penetration of the antigenic wave-
lengths is inhibited. No immunological desensitization mechanism is involved.
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